CoChat

AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity

Open access
Levenga, Josien, Wong, Helen, Milstead, Ryan A, Keller, Bailey N, LaPlante, Lauren E, Hoeffer, Charles A · 2017 · eLife

Published version of a preprint

Cited by 106

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

AKT is a kinase regulating numerous cellular processes in the brain, and mutations in AKT are known to affect brain function. AKT is indirectly implicated in synaptic plasticity, but its direct role has not been studied. Moreover, three highly related AKT isoforms are expressed in the brain, but their individual roles are poorly understood. We find in Mus musculus, each AKT isoform has a unique expression pattern in the hippocampus, with AKT1 and AKT3 primarily in neurons but displaying local differences, while AKT2 is in astrocytes. We also find isoform-specific roles for AKT in multiple paradigms of hippocampal synaptic plasticity in area CA1. AKT1, but not AKT2 or AKT3, is required for L-LTP through regulating activity-induced protein synthesis. Interestingly, AKT activity inhibits mGluR-LTD, with overlapping functions for AKT1 and AKT3. In summary, our studies identify distinct expression patterns and roles in synaptic plasticity for AKT isoforms in the hippocampus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.30640

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 46

  1. Antion, 2008, mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice, Molecular and Cellular Biology, 28, 2996, 10.1128/MCB.00201-08 · DOI · Paper page
  2. Antion, 2008, Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity, Learning & Memory, 15, 29, 10.1101/lm.661908 · DOI · Paper page
  3. Bergeron, 2017, Genetic deletion of Akt3 induces an endophenotype reminiscent of psychiatric manifestations in mice, Frontiers in Molecular Neuroscience, 10, 102, 10.3389/fnmol.2017.00102 · DOI
  4. Bowling, 2014, Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity, Science Signaling, 7, ra4, 10.1126/scisignal.2004331 · DOI
  5. Chan, 2011, Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity, PNAS, 108, E1120, 10.1073/pnas.1109879108 · DOI
  6. Cho, 2001, Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta), Science, 292, 1728, 10.1126/science.292.5522.1728 · DOI · Paper page
  7. Cho, 2001, Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice, Journal of Biological Chemistry, 276, 38349, 10.1074/jbc.C100462200 · DOI · Paper page
  8. Easton, 2005, Role for Akt3/protein kinase Bgamma in attainment of normal brain size, Molecular and Cellular Biology, 25, 1869, 10.1128/MCB.25.5.1869-1878.2005 · DOI · Paper page
  9. Emamian, 2004, Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia, Nature Genetics, 36, 131, 10.1038/ng1296 · DOI · Paper page
  10. English, 2015, Reduced protein synthesis in schizophrenia patient-derived olfactory cells, Translational Psychiatry, 5, e663, 10.1038/tp.2015.119 · DOI
  11. Frech, 1997, High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity, Journal of Biological Chemistry, 272, 8474, 10.1074/jbc.272.13.8474 · DOI · Paper page
  12. Gai, 2015, Phenotypes of AKT3 deletion: a case report and literature review, American Journal of Medical Genetics. Part A, 167A, 174, 10.1002/ajmg.a.36710 · DOI
  13. Gallagher, 2004, Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1, Journal of Neuroscience, 24, 4859, 10.1523/JNEUROSCI.5407-03.2004 · DOI · Paper page
  14. George, 2004, A family with severe insulin resistance and diabetes due to a mutation in AKT2, Science, 304, 1325, 10.1126/science.1096706 · DOI · Paper page
  15. Hatzimanolis, 2013, Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients, Translational Psychiatry, 3, e264, 10.1038/tp.2013.33 · DOI
  16. Hers, 2011, Akt signalling in health and disease, Cellular Signalling, 23, 1515, 10.1016/j.cellsig.2011.05.004 · DOI · Paper page
  17. Hino, 2016, Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia, Journal of Psychiatric Research, 82, 100, 10.1016/j.jpsychires.2016.07.018 · DOI
  18. Hoeffer, 2013, Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation, Journal of Neurophysiology, 109, 68, 10.1152/jn.00342.2012 · DOI · Paper page
  19. Hoeffer, 2008, Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior, Neuron, 60, 832, 10.1016/j.neuron.2008.09.037 · DOI · Paper page
  20. Horwood, 2006, Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat, European Journal of Neuroscience, 23, 3375, 10.1111/j.1460-9568.2006.04859.x · DOI · Paper page
  21. Huber, 2000, Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression, Science, 288, 1254, 10.1126/science.288.5469.1254 · DOI · Paper page
  22. Huber, 2001, Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1, Journal of Neurophysiology, 86, 321, 10.1152/jn.2001.86.1.321 · DOI · Paper page
  23. Hutchinson, 2011, Regulation of ribosomal protein S6 phosphorylation by casein kinase 1 and protein phosphatase 1, Journal of Biological Chemistry, 286, 8688, 10.1074/jbc.M110.141754 · DOI · Paper page
  24. Ito, 1992, 3,5-Dihydroxyphenyl-glycine: a potent agonist of metabotropic glutamate receptors, Neuroreport, 3, 1013, 10.1097/00001756-199211000-00017 · DOI · Paper page
  25. Kumar, 2005, AKT crystal structure and AKT-specific inhibitors, Oncogene, 24, 7493, 10.1038/sj.onc.1209087 · DOI · Paper page
  26. Kumarasinghe, 2013, Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication, The International Journal of Neuropsychopharmacology, 16, 1483, 10.1017/S1461145713000035 · DOI · Paper page
  27. Leavens, 2009, Akt2 is required for hepatic lipid accumulation in models of insulin resistance, Cell Metabolism, 10, 405, 10.1016/j.cmet.2009.10.004 · DOI · Paper page
  28. Levenga, 2013, Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments, Acta Neuropathologica Communications, 1, 34, 10.1186/2051-5960-1-34 · DOI · Paper page
  29. Liu, 2011, The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway, The Journal of Clinical Endocrinology & Metabolism, 96, E577, 10.1210/jc.2010-2644 · DOI
  30. Nakai, 2014, Girdin phosphorylation is crucial for synaptic plasticity and memory: a potential role in the interaction of BDNF/TrkB/Akt signaling with NMDA receptor, Journal of Neuroscience, 34, 14995, 10.1523/JNEUROSCI.2228-14.2014 · DOI
  31. O' Neill, 2013, PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease, Experimental Gerontology, 48, 647, 10.1016/j.exger.2013.02.025 · DOI · Paper page
  32. Okuzumi, 2009, Inhibitor hijacking of Akt activation, Nature Chemical Biology, 5, 484, 10.1038/nchembio.183 · DOI · Paper page
  33. Papouin, 2017, Astrocytic control of synaptic function, Philosophical Transactions of the Royal Society B: Biological Sciences, 372, 20160154, 10.1098/rstb.2016.0154 · DOI · Paper page
  34. Peineau, 2007, LTP inhibits LTD in the hippocampus via regulation of GSK3beta, Neuron, 53, 703, 10.1016/j.neuron.2007.01.029 · DOI · Paper page
  35. Pen, 2016, Membrane-tethered AKT kinase regulates basal synaptic transmission and early phase LTP expression by modulation of post-synaptic AMPA receptor level, Hippocampus, 26, 1149, 10.1002/hipo.22597 · DOI
  36. Potter, 2013, Reduced juvenile long-term depression in tuberous sclerosis complex is mitigated in adults by compensatory recruitment of mGluR5 and Erk signaling, PLoS Biology, 11, e1001627, 10.1371/journal.pbio.1001627 · DOI
  37. Sweatt, 2016, Neural plasticity and behavior - sixty years of conceptual advances, Journal of Neurochemistry, 139, 179, 10.1111/jnc.13580 · DOI · Paper page
  38. Tronche, 1999, Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety, Nature Genetics, 23, 99, 10.1038/12703 · DOI · Paper page
  39. Tschopp, 2005, Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis, Development, 132, 2943, 10.1242/dev.01864 · DOI · Paper page
  40. van Beveren, 2012, Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients, PLoS One, 7, e32618, 10.1371/journal.pone.0032618 · DOI
  41. Wan, 2012, Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity, Molecular and Cellular Biology, 32, 96, 10.1128/MCB.05806-11 · DOI
  42. Wong, 2015, RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease, Acta Neuropathologica, 130, 829, 10.1007/s00401-015-1499-8 · DOI · Paper page
  43. Wymann, 2003, Phosphoinositide 3-kinase signalling--which way to target?, Trends in Pharmacological Sciences, 24, 366, 10.1016/S0165-6147(03)00163-9 · DOI · Paper page
  44. Yang, 2005, Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice, Molecular and Cellular Biology, 25, 10407, 10.1128/MCB.25.23.10407-10418.2005 · DOI · Paper page
  45. Zhang, 2010, AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion, Oncology Reports, 24, 65
  46. Zhang, 2016, A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell type, Oncology Letters, 11, 1685, 10.3892/ol.2016.4111 · DOI

Cited by

Metadata

Authors
Levenga, J., Wong, H., Milstead, R. A., Keller, B. N., LaPlante, L. E., & Hoeffer, C. A.
Venue
eLife
Published
2017-11-27
Volume
6
ISSN
2050-084X (ISSN-L)
OpenAlex
W2737643226
Cited by
106
References
10
FWCI
2.70
Type
journal article
Language
en
Open access
gold
Funders
  • Sie Foundation
  • National Institutes of Health (F31 NS083277, T32 MH019524, R01 NS086933)
  • Alzheimer's Association (MNIRGDP-12-258900)
  • Simons Foundation (SFARI 27444)
  • Linda Crnic Institute for Down Syndrome (Seed Grant)
  • National Alliance for Research on Schizophrenia and Depression (21069)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.